Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-13 Sale |
2024-03-13 4:36 pm |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
8,891 | $162.16 | $1,441,765 | 15,043 (Direct) |
View |
| 2024-02-16 Sale |
2024-03-06 3:42 pm |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
3,725 | $25.81 | $96,142 | 4,103,430 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-05 Option Award |
2024-03-07 4:58 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Woods Eugene A. Director |
753 | $159.8 | 1,245 (Direct) |
View |
| 2024-03-05 Option Award |
2024-03-07 4:58 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
235 | $159.8 | 8,788 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
584 | $1.186 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
252 | $3.955 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
2,940 | $0.237 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A 2024-11-18 |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
3,855 | $0 | 4,103,430 (Indirect) |
View |
| 2024-02-16 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
607,725 | $0.158 | 4,103,430 (Indirect) |
View |
| 2024-02-16 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
607,225 | $0 | 4,103,430 (Indirect) |
View |
| 2024-02-29 Exercise |
2024-03-06 3:42 pm |
N/A N/A |
CVRx Inc. | CVRX | JOHNSON & JOHNSON Johnson & Johnson Innovation - JJDC Inc. 10% Owner |
79 | $5.141 | 4,103,430 (Indirect) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:58 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
81,763 | $0 | 81,763 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:56 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
31,094 | $0 | 31,094 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:56 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
52,743 | $0 | 52,743 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Hait William EVP, Chief EI and Med Officer |
36,851 | $0 | 36,851 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
25,220 | $0 | 25,220 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Innovative Medicine, R&D |
69,211 | $0 | 69,211 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
101,110 | $0 | 101,110 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:55 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
49,289 | $0 | 49,289 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:54 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
188,862 | $0 | 188,862 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:54 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
43,070 | $0 | 43,070 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:54 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
25,220 | $0 | 25,220 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-20 5:54 pm |
N/A 2034-02-15 |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
9,191 | $0 | 9,191 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
651 | $0 | 83,913 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
333 | $157.85 | 83,913 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
1,780 | $0 | 74,496 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
773 | $157.85 | 74,496 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
1,302 | $0 | 157,455 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
666 | $157.85 | 157,455 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
447 | $0 | 15,464 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
195 | $157.85 | 15,464 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
499 | $0 | 14,784 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
250 | $157.85 | 14,784 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
925 | $0 | 113,924 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
474 | $157.85 | 113,924 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
834 | $0 | 40,313 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
427 | $157.85 | 40,313 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
3,470 | $0 | 371,124 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
1,507 | $157.85 | 371,124 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
651 | $0 | 9,642 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
236 | $157.85 | 9,642 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
408 | $0 | 24,750 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
209 | $157.85 | 24,750 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
313 | $0 | 20,328 (Direct) |
View |
| 2024-02-13 Tax Withholding |
2024-02-15 4:53 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
86 | $157.85 | 20,328 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
2,136 | $157.4 | 23,735 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
790 | $0 | 23,735 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Broadhurst Vanessa EVP, Global Corp Affairs |
4,701 | $0 | 23,735 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
4,076 | $157.4 | 38,240 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
8,932 | $0 | 38,240 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
10,816 | $157.4 | 69,931 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
25,835 | $0 | 69,931 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
1,034 | $157.4 | 7,925 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Forminard Elizabeth Executive VP, General Counsel |
2,859 | $0 | 7,925 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
13,403 | $157.4 | 154,215 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WWC. Innovative Medicine |
26,202 | $0 | 154,215 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
7,019 | $157.4 | 111,625 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
14,960 | $0 | 111,625 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
1,695 | $157.4 | 14,318 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. EVP, CIO |
5,456 | $0 | 14,318 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
15,900 | $157.4 | 362,222 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
36,618 | $0 | 362,222 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
2,887 | $157.4 | 13,537 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
5,736 | $0 | 13,537 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
523 | $157.4 | 19,477 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Decker Robert J VP Corporate Controller |
1,912 | $0 | 19,477 (Direct) |
View |
| 2024-02-12 Tax Withholding |
2024-02-14 6:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
7,066 | $157.4 | 82,293 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-14 6:36 pm |
2024-02-08 N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
13,813 | $0 | 82,293 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:18 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
27,333 | $156.76 | 75,546 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:18 pm |
2017-02-11 2024-02-09 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
35,638 | $90.44 | 75,546 (Direct) |
View |
| 2024-02-09 Tax Withholding |
2024-02-13 5:18 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
98,662 | $156.76 | 341,504 (Direct) |
View |
| 2024-02-09 Exercise |
2024-02-13 5:18 pm |
2017-02-11 2024-02-09 |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
130,969 | $90.44 | 341,504 (Direct) |
View |